These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17070643)

  • 41. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV; Urrutia CR; Martinez GR; Loyola G; Bronfman M
    J Cell Physiol; 2008 Nov; 217(2):367-76. PubMed ID: 18543250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.
    Burger-van Paassen N; Vincent A; Puiman PJ; van der Sluis M; Bouma J; Boehm G; van Goudoever JB; van Seuningen I; Renes IB
    Biochem J; 2009 May; 420(2):211-9. PubMed ID: 19228118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of PPARgamma is reduced by medium supplementation with L-glutamine in human colorectal Caco-2 cells.
    Fiatte C; Huin C; Collet P; Plénat F; Dauça M; Schohn H
    Int J Mol Med; 2008 Dec; 22(6):825-32. PubMed ID: 19020782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C; Tsantili-Kakoulidou A; Theocharis S
    Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation.
    Shimizu M; Yamashita D; Yamaguchi T; Hirose F; Osumi T
    Mol Cell Biochem; 2006 Jun; 286(1-2):33-42. PubMed ID: 16534556
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient isolation of regulatory sequences from human genome and BAC DNA.
    Xu HM; Zhang S; Liu DP; Li XG; Hao DL; Liang CC
    Biochem Biophys Res Commun; 2002 Jan; 290(3):1079-83. PubMed ID: 11798185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The human kallikrein 10 promoter contains a functional retinoid response element.
    Zeng M; Zhang Y; Bhat I; Wazer DE; Band H; Band V
    Biol Chem; 2006 Jun; 387(6):741-7. PubMed ID: 16800735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new retinoid-like compound that activates peroxisome proliferator-activated receptors and lowers blood glucose in diabetic mice.
    Deng T; Shan S; Li ZB; Wu ZW; Liao CZ; Ko B; Lu XP; Cheng J; Ning ZQ
    Biol Pharm Bull; 2005 Jul; 28(7):1192-6. PubMed ID: 15997096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The insulin-like growth factor-binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors.
    Degenhardt T; Matilainen M; Herzig KH; Dunlop TW; Carlberg C
    J Biol Chem; 2006 Dec; 281(51):39607-19. PubMed ID: 17062566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements.
    Yamamoto T; Kyo M; Kamiya T; Tanaka T; Engel JD; Motohashi H; Yamamoto M
    Genes Cells; 2006 Jun; 11(6):575-91. PubMed ID: 16716189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PPAR SUMOylation: some useful experimental tips.
    Pourcet B; Staels B; Glineur C
    Methods Mol Biol; 2013; 952():145-61. PubMed ID: 23100230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery.
    Nielsen R; Grøntved L; Stunnenberg HG; Mandrup S
    Mol Cell Biol; 2006 Aug; 26(15):5698-714. PubMed ID: 16847324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets.
    Holland CM; Saidi SA; Evans AL; Sharkey AM; Latimer JA; Crawford RA; Charnock-Jones DS; Print CG; Smith SK
    Mol Cancer Ther; 2004 Aug; 3(8):993-1001. PubMed ID: 15299082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meta-analysis of primary target genes of peroxisome proliferator-activated receptors.
    Heinäniemi M; Uski JO; Degenhardt T; Carlberg C
    Genome Biol; 2007; 8(7):R147. PubMed ID: 17650321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics.
    Lemay DG; Hwang DH
    J Lipid Res; 2006 Jul; 47(7):1583-7. PubMed ID: 16585784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dominant-negative and knockdown approaches to studying PPAR activity.
    Singh S; Bennett RG
    Methods Mol Biol; 2013; 952():87-98. PubMed ID: 23100226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DIP-chip: rapid and accurate determination of DNA-binding specificity.
    Liu X; Noll DM; Lieb JD; Clarke ND
    Genome Res; 2005 Mar; 15(3):421-7. PubMed ID: 15710749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolution and expression of chimeric POTE-actin genes in the human genome.
    Lee Y; Ise T; Ha D; Saint Fleur A; Hahn Y; Liu XF; Nagata S; Lee B; Bera TK; Pastan I
    Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17885-90. PubMed ID: 17101985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloning of an antibody binding DNA sequence: pitfalls of DNA/protein immunoprecipitation reactions.
    Weitzmann MN; Savage N
    J Immunol Methods; 1994 Jul; 173(1):7-10. PubMed ID: 8034988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a Metabolism-Related Risk Signature Associated With Clinical Prognosis in Glioblastoma Using Integrated Bioinformatic Analysis.
    He Z; Wang C; Xue H; Zhao R; Li G
    Front Oncol; 2020; 10():1631. PubMed ID: 33042807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.